Cefazolin for Injection, USP, 1 gram per vial, Sterile, For Intramuscular or Intravenous Use, Rx ...

FDA Recall #D-0569-2025 — Class I — June 27, 2025

Recall #D-0569-2025 Date: June 27, 2025 Classification: Class I Status: Ongoing

Product Description

Cefazolin for Injection, USP, 1 gram per vial, Sterile, For Intramuscular or Intravenous Use, Rx Only, Manufactured by Sandoz GmbH for Sandoz Inc. Princeton, NJ 08540, NDC: 0781 3451-70 (vial), NDC: 0781-3451-96 (carton).

Reason for Recall

Labeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection, USP, 20 million Unit. The vials contained Cefozalin

Recalling Firm

Sandoz Inc — Princeton, NJ

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

208,300 vials

Distribution

Nationwide in the USA

Code Information

Lot # PG4360, PG4362, Exp. 11/30/2027

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated